RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress
Drug Resistance Updates · 2026
DOI: 10.1016/j.drup.2026.101375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2026. Verfasst von Jiajing Luo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Endoplasmic Reticulum Stress, Ubiquitin-Protein Ligases. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Cancer Hospital.
Abstract (Originalsprache)
OBJECTIVE: To investigate the role and molecular mechanism of the E3 ubiquitin ligase RNF26 in regulating the immunogenicity of hepatocellular carcinoma (HCC). METHODS: We integrated multi-omics analyses of clinical HCC specimens with different immunogenicity, established HCC models using hepatocyte-specific Rnf26 knockout mice, and employed in vitro 3D tumor-T cell co-culture systems, RNA-seq, molecular interaction assays, and pharmacological inhibition to systematically examine RNF26's regulation of T cell function, antigen presentation, and endoplasmic reticulum (ER) stress. RESULTS: RNF26 was highly expressed in immune-"cold" HCC, and its transcription was directly regulated by the inflammatory JAK-STAT3 axis. In HCC cells, RNF26 degraded the ER chaperone GRP78 via K48-linked polyubiquitination, inducing sustained ER stress. This resulted in diminished MHC-I antigen presentation and increased PD-L1 expression. This mechanism consistently inhibited CD8+ T cell infiltration, promoted T cell exhaustion, and drove immune evasion in both in vivo and in vitro models. Inhibiting ER stress reversed the RNF26-mediated immunosuppressive phenotype. CONCLUSION: RNF26 is a pivotal molecular node linking the inflammatory microenvironment to immune suppression in HCC. By ubiquitinating and degrading GRP78 to instigate ER stress, it dually regulates antigen presentation and immune checkpoint expression. Targeting the RNF26-GRP78 axis represents a promising novel strategy for reversing HCC immune resistance and enhancing the efficacy of immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School of Nanjing University, Nanjing, China.
- General Surgery Department, Jiangsu Cancer Hospital &, Jiangsu Institute of Cancer Research &, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
- Department of Laboratory Medicine, First Affiliated Hospital of Anhui Medical University, Anhui, China.
- Department of Gastroenterology, Affiliated Nanjing Drum Tower Hospital, and, Medical School of Nanjing University, Nanjing, Jiangsu Province 210008, China.
- Division of Hepatobilliary Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China. Electronic address: xcailin1201@163.c…
- Medical School of Nanjing University, Nanjing, China. Electronic address: jiangrq@nju.edu.cn.
Förderung
- National Natural Science Foundation of China
- Jiangsu Cancer Hospital
Zitieren
APA
Luo, J., Zhuo, H., Zheng, M., Fang, Y., Wang, X., Jin, Y., Li, Y., Du, S., Wang, J., Xue, C., Jiang, R., & Li, G. (2026). RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101375
Vancouver
Luo J, Zhuo H, Zheng M, Fang Y, Wang X, Jin Y, et al. RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress. Drug Resistance Updates. 2026. doi:10.1016/j.drup.2026.101375
BibTeX
@article{Luo2026,
author = {Luo, Jiajing and Zhuo, Han and Zheng, Minghui and Fang, Yi and Wang, Xuran and Jin, Yangyang and Li, Yaoyao and Du, Siyu and Wang, Jie and Xue, Cailin and Jiang, Runqiu and Li, Gang},
title = {RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress},
journal = {Drug Resistance Updates},
year = {2026},
doi = {10.1016/j.drup.2026.101375}
}
EUVIMED